4-76176503-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_005506.4(SCARB2):​c.638A>G​(p.Tyr213Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000048 in 1,459,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y213S) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

SCARB2
NM_005506.4 missense

Scores

5
13

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 4.99

Publications

0 publications found
Variant links:
Genes affected
SCARB2 (HGNC:1665): (scavenger receptor class B member 2) The protein encoded by this gene is a type III glycoprotein that is located primarily in limiting membranes of lysosomes and endosomes. Earlier studies in mice and rat suggested that this protein may participate in membrane transportation and the reorganization of endosomal/lysosomal compartment. The protein deficiency in mice was reported to impair cell membrane transport processes and cause pelvic junction obstruction, deafness, and peripheral neuropathy. Further studies in human showed that this protein is a ubiquitously expressed protein and that it is involved in the pathogenesis of HFMD (hand, foot, and mouth disease) caused by enterovirus-71 and possibly by coxsackievirus A16. Mutations in this gene caused an autosomal recessive progressive myoclonic epilepsy-4 (EPM4), also known as action myoclonus-renal failure syndrome (AMRF). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
SCARB2 Gene-Disease associations (from GenCC):
  • action myoclonus-renal failure syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • progressive myoclonus epilepsy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Unverricht-Lundborg syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.795

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005506.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCARB2
NM_005506.4
MANE Select
c.638A>Gp.Tyr213Cys
missense
Exon 5 of 12NP_005497.1
SCARB2
NM_001204255.2
c.276-593A>G
intron
N/ANP_001191184.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCARB2
ENST00000264896.8
TSL:1 MANE Select
c.638A>Gp.Tyr213Cys
missense
Exon 5 of 12ENSP00000264896.2
SCARB2
ENST00000640634.1
TSL:5
c.758A>Gp.Tyr253Cys
missense
Exon 6 of 13ENSP00000492737.1
SCARB2
ENST00000639145.1
TSL:5
c.629A>Gp.Tyr210Cys
missense
Exon 5 of 12ENSP00000492831.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000480
AC:
7
AN:
1459176
Hom.:
0
Cov.:
29
AF XY:
0.00000138
AC XY:
1
AN XY:
726020
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33434
American (AMR)
AF:
0.00
AC:
0
AN:
44650
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39658
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86010
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52828
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00000450
AC:
5
AN:
1110386
Other (OTH)
AF:
0.00
AC:
0
AN:
60328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.404
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.58
BayesDel_addAF
Uncertain
0.14
D
BayesDel_noAF
Uncertain
-0.040
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.77
D
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.40
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.97
D
M_CAP
Uncertain
0.22
D
MetaRNN
Pathogenic
0.79
D
MetaSVM
Uncertain
0.28
D
MutationAssessor
Pathogenic
3.4
M
PhyloP100
5.0
PrimateAI
Uncertain
0.63
T
PROVEAN
Pathogenic
-6.6
D
REVEL
Pathogenic
0.70
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.0080
D
Polyphen
1.0
D
Vest4
0.83
MutPred
0.64
Gain of glycosylation at Y213 (P = 0.0418)
MVP
0.90
MPC
0.98
ClinPred
0.99
D
GERP RS
4.2
Varity_R
0.98
gMVP
0.99
Mutation Taster
=22/78
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs751953388; hg19: chr4-77097656; API